Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Betina Ip and brain illustration

Dr Betina Ip has been awarded a Dorothy Hodgkin Fellowship by the Royal Society, for her research ' Investigating the neurochemistry of human binocular perception and plasticity using advanced in vivo high field MR spectroscopy.’ The fellowship offers a recognised first step into an independent research career for outstanding post-doctoral scientists who need a flexible working pattern due to parenting or caring responsibilities.

Dr Ip’s award will support her research on neuroplasticity in the healthy and developmentally abnormal binocular visual system. Her research can inform treatments for ‘lazy eye’, the most common visual pathology in children that is associated with loss of normal binocular vision.

A better understanding on what promotes and limits plasticity in the brain is critical for treating neurodevelopmental disorders as well as for recovery from brain injury and disease. Animal studies have shown that the inhibitory neurotransmitter GABA is an essential part of experience-dependent plasticity in the developing brain. Magnetic Resonance Spectroscopy, a non-invasive brain imaging technique, is the only method that can measure GABA levels in the living human brain. By being sensitive to the minute shifts in the magnetic resonance signal of protons generated by the chemical structure of metabolites, MRS detects and quantifies their concentrations. 

Using this ‘chemical’ camera, a major goal of Betina’s research will be to take pictures of GABA concentrations in the visual cortex of participants who learn to see better using two eyes. Through this work, she aims to understand how the adult brain reorganises due to sensory experience. 

Read more on the Royal Society website.

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New Academic Visitor from Nigeria

Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

New Year's Honours for Professor Irene Tracey

Professor Irene Tracey FMedSci, MAE, Professor of Anaesthetic Neuroscience and Warden of Merton College, has been appointed CBE for services to medical research.

Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.